2022 annual financial data
Gyre Therapeutics 2022 Financial results
Direct answer
Revenue was 102,290,000 CNY.
Operating income was 9,203,000 CNY and net income was 2,302,000 CNY.
Operating cash flow was 10,677,000 CNY.
Get free Gyre Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 102,290,000 CNY
- Operating income
- 9,203,000 CNY
- Net income
- 2,302,000 CNY
- Operating cash flow
- 10,677,000 CNY
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Gyre Therapeutics financial years